Literature DB >> 31476984

Margins in Laryngeal Squamous Cell Carcinoma Treated with Transoral Laser Microsurgery: A National Database Study.

Jonathan Hanna1, Philip R Brauer1, Elliot Morse1, Saral Mehra2.   

Abstract

OBJECTIVES: To determine national positive margin rates in transoral laser microsurgery, to compare patients with positive and negative margins, and to identify factors associated with positive margins. STUDY
DESIGN: Retrospective review of the National Cancer Database.
SETTING: Population based. SUBJECTS/
METHODS: Patients included those with TIS-T3 laryngeal squamous cell carcinoma (2004-2014). Univariable and multivariable logistic regression were used to identify predictors.
RESULTS: A total of 1959 patients met inclusion criteria. The national positive margin rate was 22.3%. Sixty-five percent of patients had T1 disease; 94.3% were N-negative; and 74.0% had glottic tumors. Fifty-eight percent of patients were treated at academic centers, and 60.6% were treated at facilities performing <2 cases per year. On multivariable analysis, factors associated with margin status included facility volume (odds ratio [95% CI]; in cases per year: 0.93 [0.89-0.97], P = .001), academic status (vs nonacademic; academic: 0.70 [0.54-0.90], P = .008), T-stage (vs T1; T2: 2.74 [2.05-3.65], T3: 5.53 [3.55-8.63], TIS: 0.59 [0.38-0.92], P < .001), and N-stage (vs N0; N1: 3.42 [1.79-6.54], N2: 2.01 [1.09-3.69], P < .001). Tumor subsite was not associated with margin status.
CONCLUSION: The national positive margin rate for laryngeal laser surgery is 22%, which is concerning given the equivalent survival benefit offered by surgery and primary radiation and the increased likelihood of bimodal therapy in the situation of positive margins. Cases treated at nonacademic centers and those with lower caseloads had a higher likelihood of positive margins. There was a linear association between T-stage and likelihood of positive margins, with T3 tumors being 5 times as likely as T1 to yield positive margins. This study highlights the importance of proper patient selection for transoral laser microsurgery resections.

Entities:  

Keywords:  laryngeal cancer; margin status; transoral laser microsurgery

Mesh:

Year:  2019        PMID: 31476984     DOI: 10.1177/0194599819874315

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  Quantifying Tumor and Vasculature Deformations during Laryngoscopy.

Authors:  Xiaotian Wu; David A Pastel; Rihan Khan; Clifford J Eskey; Yuan Shi; Michael Sramek; Joseph A Paydarfar; Ryan J Halter
Journal:  Ann Biomed Eng       Date:  2022-01-07       Impact factor: 4.219

2.  [Larynx preservation: recommendations for decision-making in T3 laryngeal cancer patients].

Authors:  Gerhard Dyckhoff; Rolf Warta; Christel Herold-Mende; Peter K Plinkert; Heribert Ramroth
Journal:  HNO       Date:  2022-05-16       Impact factor: 1.330

3.  A modular surgical simulator for microlaryngoscopy using standard instruments and the carbon dioxide laser.

Authors:  Sara E Bressler; Lacey K Adkins; Michael E Dunham; Rohan R Walvekar; Jangwook P Jung; Jorge A Belgodere; Adam X Bao; Lizabeth S Breaux; Hunter C Lee; Soheil Saneei; Austin P Veal; John S Carleton
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-06-30

4.  Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients.

Authors:  Gerhard Dyckhoff; Rolf Warta; Christel Herold-Mende; Elisabeth Rudolph; Peter K Plinkert; Heribert Ramroth
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

5.  T1 glottic laryngeal cancer: the role of routine follow-up visits in detecting local recurrence.

Authors:  Pihla Pakkanen; Taru Ilmarinen; Elina Halme; Heikki Irjala; Petri Koivunen; Matti Pukkila; Sami Ventelä; Jaana Hagström; Leena-Maija Aaltonen
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-08-06       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.